Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

*The Co-Dx PCR platform (including the Co-Dx PCR Home (TM), Co-Dx PCR Pro (TM), mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is ...

CAAR ruled that multi-functional PCR instruments cannot be treated as spectrometers where optical detection is only one part ...

By Dr. Liji Thomas, MD A new same-day detection strategy shows how simple, low-cost lab steps can uncover Salmonella in meats ...

The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...

Global Influenza Diagnostics Market OverviewThe global influenza diagnostics market is projected to expand at a CAGR of 5–8% over the next five years. Market growth is fueled by the rising prevalence ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

France becomes Seegene's ninth overseas sales subsidiary and third in Europe, following Italy and Germany - The country ranks as Europe's second-largest molec ...

Core to Seegene Mexico are the Allplex and Anyplex HPV 28 Detection assays – real-time multiplexing PCR tests that identify ...

USA Esoteric Testing Market is expected to show increasing and is expected to grow at a CAGR of ~$% from 2022 to 2028 with the need for early detection & diagnosis & rapid technological advancements ...

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of ...